ARTICLE | Management Tracks
Sanofi hires Kayath, veteran of BioMarin and Novartis, as CMO
Plus: Leave of absence for Hutchmed CEO and updates from Rocket, Harbour BioMed, Strand, Acadia
August 27, 2025 1:13 AM UTC
Next week, Marcia Kayath will join Sanofi (Euronext:SAN; NASDAQ:SNY) as CMO. She joins from BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), where she was VP and global head of medical affairs; she also had a 17-year career at Novartis AG (SIX:NOVN; NYSE:NVS), serving for more than three years as CMO and global head of medical affairs.
Hutchmed China Ltd. (LSE:HCM; NASDAQ:HCM; HKEX:0013) said CEO Weiguo Su will take a leave of absence from the company for medical reasons. CFO Johnny Cheng will fill the role at the oncology and immunology company on an acting basis...